Delivery for Special Products. 1. Wholesaler will maintain appropriate temperatures and environmental conditions in accordance with manufacturer requirements for delivery to the MMCAP Infuse Participating Facilities. All refrigerated Products will be shipped in returnable coolers with appropriate packaging to maintain the required temperature range. Products requiring refrigeration will be clearly marked as such. Wholesaler will use phase change panels to maintain orders at proper temperatures. 2. All Products will be adequately packaged by Wholesaler. If an MMCAP Infuse Participating Facility refuses Product that has been inadequately packaged, the MMCAP Infuse Participating Facility must notify Wholesaler’s customer service department to log the complaint. Any costs associated with the return of Product due to improper packaging or transport will be at the expense of the Wholesaler. 3. Wholesaler will comply with all DEA requirements for controlled substances. To help ensure that the Wholesaler is operating within full compliance of all applicable laws, rules and regulations, Wholesaler deploys a Suspicious Order Monitoring (SOM) program. This program uses threshold methodology that is continually developed and refined by Wholesaler’s Quality and Regulatory Affairs (QRA) department. The methodology is based upon a variety of factors, including the prescription volume of the pharmacy and the historical purchase volumes supplied to Wholesaler. Each unique DEA number within the MMCAP Infuse Member's network will have its own customized ordering thresholds. MMCAP Infuse Participating Facilities’ orders will be tracked according to the above-described methodology. Wholesaler will communicate with the MMCAP Infuse Participating Facility’s pharmacy personnel before thresholds are reached, to allow the MMCAP Infuse Participating Facility to conduct a review of their pharmacy’s purchases and to determine the legitimacy of those orders in light any changes in purchases for that particular DEA-registered location. In the event that regulatory action is taken against a distribution center, the Wholesaler will ensure continuity of product delivers to the impacted MMCAP Infuse Members by shipping controlled substances from a back-up distribution center, already identified as part of Business Continuity planning.
Appears in 5 contracts
Samples: Pharmaceutical Prime Wholesaler Services Contract, Pharmaceutical Prime Wholesaler Services Contract, Pharmaceutical Prime Wholesaler Services Contract